Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
Tóm tắt
Từ khóa
Tài liệu tham khảo
Coscas F, Coscas G, Souied E, Tick S, Soubrane G . Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007; 144 (4): 592–599.
Pepple K, Mruthyunjaya P . Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options. Semin Ophthalmol 2011; 26 (3): 198–208.
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991; 109 (9): 1220–1231.
Arias L . Treatment of retinal pigment epithelial detachment with antiangiogenic therapy. Clin Ophthalmol 2010; 4: 369–374.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et alMARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419–1431.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et alANCHOR Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1432–1444.
Ohr M, Kaiser PK . Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opin Pharmacother 2012; 13 (4): 585–591.
Pauleikhoff D, Loffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240 (7): 533–538.
Cho M, Barbazetto IA, Freund KB . Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 2009; 148 (1): 70–78.
Binder S . Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance? Br J Ophthalmol 2012; 96 (1): 1–2.
Eghoj MS, Sorensen TL . Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol 2012; 96 (1): 21–23.
Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT . Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina 2009; 29 (6): 723–731.